Free Trial

West Pharmaceutical Services (WST) Earnings Date, Estimates & Call Transcripts

West Pharmaceutical Services logo
$331.40 +4.39 (+1.34%)
(As of 12/20/2024 05:17 PM ET)

West Pharmaceutical Services Latest Earnings Summary

Actual EPS
(Oct. 24)
$1.85 Beat By $0.35
Consensus EPS
(Oct. 24)
$1.50

West Pharmaceutical Services released Q3 2024 earnings on October 24, 2024, reporting an EPS of $1.85, which topped analysts' consensus estimates of $1.50 by $0.35. Quarterly revenue fell .1% year-over-year to $746.90 million, above the consensus estimate of $709.62 million. With a trailing EPS of $6.74 and a P/E Ratio of 49.17, West Pharmaceutical Services' earnings are expected to grow 13.70% next year, from $6.64 to $7.55 per share.

Get West Pharmaceutical Services Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on West Pharmaceutical Services and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

WST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

WST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

West Pharmaceutical Services Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$1.30$2.05$1.55 
Q2 20243$1.76$2.28$2.03 
Q3 20243$1.51$2.35$2.02 
Q4 20243$1.77$2.24$1.93 
FY 202412$6.34$8.92$7.52 
Q1 20252$1.61$1.63$1.62 
Q2 20252$1.73$1.79$1.76 
Q3 20252$1.84$2.11$1.98 
Q4 20252$2.12$2.25$2.19 
FY 20258$7.30$7.78$7.54 
Q1 20261$1.89$1.89$1.89 
Q2 20261$2.17$2.17$2.17 
Q3 20261$2.11$2.11$2.11 

West Pharmaceutical Services Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/24/2024Q3 2024$1.50$1.85+$0.35$1.85$709.62M$746.90M
7/25/2024Q2 2024$1.74$1.52 -$0.22$1.53$729.36M$702.10M
4/25/2024Q1 2024$1.29$1.56+$0.27$1.57$670.62M$695.40M
2/15/2024Q4 2023$1.78$1.83+$0.05$1.83$740.43M$732.00M
10/26/2023Q3 2023$1.86$2.16+$0.30$2.18$750.31M$747.40M
7/27/2023Q2 2023$1.95$2.11+$0.16$2.16$755.71M$753.80M
4/27/2023Q1 2023$1.67$1.98+$0.31$2.11$697.28M$716.60M
2/16/2023Q4 2022$1.39$1.77+$0.38$2.18$657.16M$708.70M

West Pharmaceutical Services Earnings - Frequently Asked Questions

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earning data on Thursday, October 24, 2024. Learn more on WST's earnings history.

West Pharmaceutical Services issued an update on its FY24 earnings guidance on Thursday, October, 24th. The company provided EPS guidance of $6.55 to $6.75 for the period, compared to the consensus estimate of $6.42. The company issued revenue guidance of $2.875 billion to $2.905 billion from $2.870 billion to $2.900, compared to the consensus revenue estimate of $2.87 billion.

In the previous quarter, West Pharmaceutical Services (NYSE:WST) reported $1.85 earnings per share (EPS) to beat the analysts' consensus estimate of $1.50 by $0.35. Learn more on analysts' earnings estimate vs. WST's actual earnings.

The conference call for West Pharmaceutical Services's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for West Pharmaceutical Services's latest earnings report can be read online.
Read Transcript

West Pharmaceutical Services's earnings report can be found in their filing with the SEC.
View SEC filing

West Pharmaceutical Services (NYSE:WST) has a recorded annual revenue of $2.88 billion.

West Pharmaceutical Services (NYSE:WST) has a recorded net income of $593.40 million. WST has generated $6.74 earnings per share over the last four quarters.

West Pharmaceutical Services (NYSE:WST) has a trailing price-to-earnings ratio of 49.17 and a forward price-to-earnings ratio of 49.91. The price/earnings-to-growth ratio is 25.04.

West Pharmaceutical Services's earnings are expected to grow from $6.64 per share to $7.55 per share in the next year, which is a 13.70% increase.

More Earnings Resources from MarketBeat



This page (NYSE:WST) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners